Viking Therapeutics (LTS:0VQA) Short Interest


LTS:0VQA Viking Therapeutics Inc LTS:0VQA
37 GF Score
Price $40.50
! 3 Warning Signs
View Full Analysis

What is Viking Therapeutics Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

LTS:0VQA vs EWTX, ACAD, DNLI: Short Interest Comparison

For the Biotechnology subindustry, Viking Therapeutics's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Viking Therapeutics Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Viking Therapeutics's Short Interest distribution charts can be found below:

* The bar in red indicates where Viking Therapeutics's Short Interest falls into.


LTS:0VQA
37GF Score
Viking Therapeutics Inc LTS:0VQA
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Viking Therapeutics Business Description

Address 9920 Pacific Heights Boulevard, Suite 350, San Diego, CA, USA, 92121
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
37GF Score

Get the complete analysis for LTS:0VQA

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$40.50
Price